Abstract

Immunotherapy is currently one of the most promising treatment options for malignant melanoma. To uncover new immunological targets for future treatment approaches, single-cell transcriptomic and epigenomic analyses were performed on human primary melanoma and melanocytic nevus samples. The detailed methods of this study are described in the Supplementary Material.

Links and resources

Tags

community

  • @flgr073h
  • @scadsfct
@flgr073h's tags highlighted